Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193530 | SCV000247287 | pathogenic | Wolcott-Rallison dysplasia | 2014-11-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002517071 | SCV003324970 | pathogenic | not provided | 2022-03-15 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 210932). This variant has not been reported in the literature in individuals affected with EIF2AK3-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp522Glufs*34) in the EIF2AK3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EIF2AK3 are known to be pathogenic (PMID: 11997520). |